Treatment of sleep disorders in children

Janet C Lam1, Thornton B A Mason

  • 1Janet C. Lam, MHS, MD University of Maryland, 737 West Lombard Street, First Floor, Baltimore, MD 21201, USA. jlam@peds.umaryland.edu.

Insights

Behavioral interventions and good sleep hygiene are key for managing pediatric sleep disorders in children and adolescents. Pharmacologic treatments are limited due to a lack of pediatric drug approvals.

Area of Science:

  • Pediatric Sleep Medicine
  • Child Development
  • Behavioral Pediatrics

Background:

  • Sleep disorders significantly impact children's growth and development.
  • Behavioral interventions, including limit-setting and sleep hygiene, are primary management strategies.
  • Adolescents require specific emphasis on good sleep hygiene practices for family-wide benefit.

Purpose of the Study:

  • To review the current landscape of pediatric sleep disorder management.
  • To highlight the importance of behavioral interventions and sleep hygiene.
  • To discuss the challenges and status of pharmacologic treatments for pediatric sleep disorders.

Main Methods:

  • Literature review of pediatric sleep disorder management strategies.
  • Analysis of behavioral interventions, focusing on limit-setting and sleep hygiene.
  • Examination of the regulatory status and clinical application of pharmacologic treatments in children.

Main Results:

  • Behavioral interventions are the cornerstone of pediatric sleep disorder management.
  • Consistent limit-setting is crucial for younger children, while sleep hygiene is vital for all ages.
  • Limited US Food and Drug Administration-approved pharmacologic options exist for pediatric sleep disorders, with many treatments extrapolated from adult data.

Conclusions:

  • Behavioral strategies and consistent sleep hygiene are essential for addressing pediatric sleep disorders.
  • The scarcity of pediatric-specific pharmacologic treatments necessitates careful consideration and reliance on clinical experience and adult data extrapolation.
  • Further pediatric clinical trials are needed to expand approved pharmacologic options for children's sleep issues.

Related Concept Videos

Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
Nightmares and Night Terrors01:18

Nightmares and Night Terrors

Nightmares and night terrors represent two distinct types of sleep disturbances that differ in timing, characteristics, and the sleeper's recall of the event. Nightmares are vivid, disturbing dreams that usually awaken the sleeper from REM sleep, a stage of sleep where brain activity is high, and dreams are most frequent. Upon awakening, individuals often have detailed recollections of their nightmares, which can include themes of threats to survival, security, or self-esteem.
Nightmares often...
Narcolepsy01:07

Narcolepsy

Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
Sleepwalking and Sleep Talking01:17

Sleepwalking and Sleep Talking

Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...